Platelet Rich Plasma and Hyaluronic Acid Blend for the Treatment of Osteoarthritis: Rheological and Biological Evaluation

Fabrizio Russo, Matteo D'Este, Gianluca Vadalà, Caterina Cattani, Rocco Papalia, Mauro Alini, Vincenzo Denaro, Fabrizio Russo, Matteo D'Este, Gianluca Vadalà, Caterina Cattani, Rocco Papalia, Mauro Alini, Vincenzo Denaro

Abstract

Introduction: Osteoarthritis (OA) is the most common musculoskeletal disease. Current treatments for OA are mainly symptomatic and inadequate since none results in restoration of fully functional cartilage. Hyaluronic Acid (HA) intra-articular injections are widely accepted for the treatment of pain associated to OA. The goal of HA viscosupplementation is to reduce pain and improve viscoelasticity of synovial fluid. Platelet-rich plasma (PRP) has been also employed to treat OA to possibly induce cartilage regeneration. The combination of HA and PRP could supply many advantages for tissue repair. Indeed, it conjugates HA viscosupplementation with PRP regenerative properties. The aim of this study was to evaluate the rheological and biological properties of different HA compositions in combination with PRP in order to identify (i) the viscoelastic features of the HA-PRP blends, (ii) their biological effect on osteoarthritic chondrocytes and (iii) HA formulations suitable for use in combination with PRP.

Materials and methods: HA/PRP blends have been obtained mixing human PRP and three different HA at different concentrations: 1) Sinovial, 0.8% (SN); 2) Sinovial Forte 1.6% (SF); 3) Sinovial HL 3.2% (HL); 4) Hyalubrix 1.5% (HX). Combinations of phosphate buffered saline (PBS) and the four HA types were used as control. Rheological measurements were performed on an Anton PaarMCR-302 rheometer. Amplitude sweep, frequency sweep and rotational measurements were performed and viscoelastic properties were evaluated. The rheological data were validated performing the tests in presence of Bovine Serum Albumin (BSA) up to ultra-physiological concentration (7%). Primary osteoarthritic chondrocytes were cultured in vitro with the HA and PRP blends in the culture medium for one week. Cell viability, proliferation and glycosaminoglycan (GAG) content were assessed.

Results: PRP addition to HA leads to a decrease of viscoelastic shear moduli and increase of the crossover point, due to a pure dilution effect. For viscosupplements with HA concentration below 1% the viscoelasticity is mostly lost. Results were validated also in presence of proteins, which in synovial fluid are more abundant than HA. Chondrocytes proliferated overtime in all different culture conditions. The proliferation rate was higher in chondrocytes cultured in the media containing PRP compared to the cultures with different HA alone. GAG content was significantly higher in chondrocytes cultured in PRP and HL blend.

Discussion: We investigated the rheological and biological properties of four different HA concentrations when combined with PRP giving insights on viscoelastic and biological properties of a promising approach for future OA therapy. Our data demonstrate that PRP addition is not detrimental to the viscosupplementation effect of HA. Viscosupplements containing low HA concentration are not indicated for combination with PRP, as the viscoelastic properties are lost. Although having the same rheological behavior of SF and HX, HL was superior in stimulating extracellular matrix production in vitro.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1
(A) Viscosity curves of the pure viscosupplements. The graph represents the viscosity as a function of the shear rate. For all specimens the typical shear-thinning behavior of HA is observed. SN displays viscosity one order of magnitude lower than the other specimens. (B) Mechanical spectra of the pure viscosupplements. The graph represents the shear storage modulus G' (triangles) and the shear loss modulus G" (circle) as a function of the angular frequency.
Fig 2
Fig 2
(A): Comparison of the mechanical spectrum of pure HX and its combinations: pure HX (black); HX+PBS 1:1 (red); HX+PRP 1:1 (blue); HX+PRP pre-added to 7% BSA (dark yellow). All HX combinations show a similar rheological profile, which is dictated by the dilution effect (B): Comparison of the mechanical spectrum of pure HL and its combinations: pure HL (black); HL+PBS 1:1 (red); HL+PRP 1:1 (blue); HL+PRP pre-added to 7% BSA (dark yellow). All HL combinations show a similar rheological profile, which is dictated by the dilution effect.
Fig 3
Fig 3
(A): Mechanical spectra of HL and SF in combination with PRP. (B): Viscosity curve of HL and SF in combination with PRP.
Fig 4
Fig 4
(A): Cell viability and proliferation overtime of chondrocytes cultured under different conditions normalized to the rates of chondrocytes cultured in growing media at day 0, 3 and 7. (B): GAG content normalized to DNA of chondrocytes cultured for 7 days under different conditions compared to the GAG content of chondrocytes cultured in growing media (*: p<0.05).

References

    1. Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis and rheumatism. 2008;58(1):26–35. 10.1002/art.23176
    1. Flanigan DC, Harris JD, Trinh TQ, Siston RA, Brophy RH. Prevalence of chondral defects in athletes' knees: a systematic review. Medicine and science in sports and exercise. 2010;42(10):1795–801. 10.1249/MSS.0b013e3181d9eea0 .
    1. Goldring MB, Otero M. Inflammation in osteoarthritis. Current opinion in rheumatology. 2011;23(5):471–8. 10.1097/BOR.0b013e328349c2b1
    1. Richmond J, Hunter D, Irrgang J, Jones MH, Snyder-Mackler L, Van Durme D, et al. American Academy of Orthopaedic Surgeons clinical practice guideline on the treatment of osteoarthritis (OA) of the knee. The Journal of bone and joint surgery American volume. 2010;92(4):990–3. 10.2106/JBJS.I.00982 .
    1. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis and rheumatism. 2000;43(9):1905–15. 10.1002/1529-0131(200009)43:9<1905::AID-ANR1>;2-P .
    1. Kon E, Mandelbaum B, Buda R, Filardo G, Delcogliano M, Timoncini A, et al. Platelet-rich plasma intra-articular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: from early degeneration to osteoarthritis. Arthroscopy: the journal of arthroscopic & related surgery: official publication of the Arthroscopy Association of North America and the International Arthroscopy Association. 2011;27(11):1490–501. 10.1016/j.arthro.2011.05.011 .
    1. Zhang W, Nuki G, Moskowitz RW, Abramson S, Altman RD, Arden NK, et al. OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society. 2010;18(4):476–99. 10.1016/j.joca.2010.01.013 .
    1. Strauss EJ, Hart JA, Miller MD, Altman RD, Rosen JE. Hyaluronic acid viscosupplementation and osteoarthritis: current uses and future directions. The American journal of sports medicine. 2009;37(8):1636–44. 10.1177/0363546508326984 .
    1. Juni P, Reichenbach S, Trelle S, Tschannen B, Wandel S, Jordi B, et al. Efficacy and safety of intraarticular hylan or hyaluronic acids for osteoarthritis of the knee: a randomized controlled trial. Arthritis and rheumatism. 2007;56(11):3610–9. 10.1002/art.23026 .
    1. Baltzer AW, Moser C, Jansen SA, Krauspe R. Autologous conditioned serum (Orthokine) is an effective treatment for knee osteoarthritis. Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society. 2009;17(2):152–60. 10.1016/j.joca.2008.06.014 .
    1. Marshall KW. Intra-articular hyaluronan therapy. Foot and ankle clinics. 2003;8(2):221–32, viii. .
    1. Patti AM, Gabriele A, Vulcano A, Ramieri MT, Della Rocca C. Effect of hyaluronic acid on human chondrocyte cell lines from articular cartilage. Tissue & cell. 2001;33(3):294–300. .
    1. Prasadam I, Mao X, Shi W, Crawford R, Xiao Y. Combination of MEK-ERK inhibitor and hyaluronic acid has a synergistic effect on anti-hypertrophic and pro-chondrogenic activities in osteoarthritis treatment. Journal of molecular medicine. 2013;91(3):369–80. 10.1007/s00109-012-0953-5 .
    1. Dahl LB, Dahl IM, Engstrom-Laurent A, Granath K. Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Annals of the rheumatic diseases. 1985;44(12):817–22.
    1. Gotoh S, Onaya J, Abe M, Miyazaki K, Hamai A, Horie K, et al. Effects of the molecular weight of hyaluronic acid and its action mechanisms on experimental joint pain in rats. Annals of the rheumatic diseases. 1993;52(11):817–22.
    1. Iwata H. Pharmacologic and clinical aspects of intraarticular injection of hyaluronate. Clinical orthopaedics and related research. 1993;(289):285–91. .
    1. Jordan KM, Arden NK, Doherty M, Bannwarth B, Bijlsma JW, Dieppe P, et al. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Annals of the rheumatic diseases. 2003;62(12):1145–55.
    1. Castellacci E, Polieri T. Antalgic effect and clinical tolerability of hyaluronic acid in patients with degenerative diseases of knee cartilage: an outpatient treatment survey. Drugs under experimental and clinical research. 2004;30(2):67–73. .
    1. Moreland LW. Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action. Arthritis research & therapy. 2003;5(2):54–67.
    1. Vitanzo PC Jr., Sennett BJ. Hyaluronans: is clinical effectiveness dependent on molecular weight? American journal of orthopedics. 2006;35(9):421–8. .
    1. Handl M, Amler E, Braun K, Holzheu J, Trc T, Imhoff AB, et al. Positive effect of oral supplementation with glycosaminoglycans and antioxidants on the regeneration of osteochondral defects in the knee joint. Physiological research / Academia Scientiarum Bohemoslovaca. 2007;56(2):243–9. .
    1. Vadala G, Russo F, Di Martino A, Denaro V. Intervertebral disc regeneration: from the degenerative cascade to molecular therapy and tissue engineering. Journal of tissue engineering and regenerative medicine. 2015;9(6):679–90. 10.1002/term.1719 .
    1. Kon E, Buda R, Filardo G, Di Martino A, Timoncini A, Cenacchi A, et al. Platelet-rich plasma: intra-articular knee injections produced favorable results on degenerative cartilage lesions. Knee surgery, sports traumatology, arthroscopy: official journal of the ESSKA. 2010;18(4):472–9. 10.1007/s00167-009-0940-8 .
    1. Paoloni J, De Vos RJ, Hamilton B, Murrell GA, Orchard J. Platelet-rich plasma treatment for ligament and tendon injuries. Clinical journal of sport medicine: official journal of the Canadian Academy of Sport Medicine. 2011;21(1):37–45. 10.1097/JSM.0b013e31820758c7 .
    1. Marx RE. Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant dentistry. 2001;10(4):225–8. .
    1. Eppley BL, Woodell JE, Higgins J. Platelet quantification and growth factor analysis from platelet-rich plasma: implications for wound healing. Plastic and reconstructive surgery. 2004;114(6):1502–8. .
    1. Xie X, Zhang C, Tuan RS. Biology of platelet-rich plasma and its clinical application in cartilage repair. Arthritis research & therapy. 2014;16(1):204 10.1186/ar4493
    1. Sheth U, Simunovic N, Klein G, Fu F, Einhorn TA, Schemitsch E, et al. Efficacy of autologous platelet-rich plasma use for orthopaedic indications: a meta-analysis. The Journal of bone and joint surgery American volume. 2012;94(4):298–307. 10.2106/JBJS.K.00154 .
    1. Andia I, Sanchez M, Maffulli N. Joint pathology and platelet-rich plasma therapies. Expert opinion on biological therapy. 2012;12(1):7–22. 10.1517/14712598.2012.632765 .
    1. Malhotra R, Kumar V, Garg B, Singh R, Jain V, Coshic P, et al. Role of autologous platelet-rich plasma in treatment of long-bone nonunions: a prospective study. Musculoskeletal surgery. 2015. 10.1007/s12306-015-0378-8 .
    1. Di Matteo B, Filardo G, Kon E, Marcacci M. Platelet-rich plasma: evidence for the treatment of patellar and Achilles tendinopathy—a systematic review. Musculoskeletal surgery. 2015;99(1):1–9. 10.1007/s12306-014-0340-1 .
    1. Zhu Y, Yuan M, Meng HY, Wang AY, Guo QY, Wang Y, et al. Basic science and clinical application of platelet-rich plasma for cartilage defects and osteoarthritis: a review. Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society. 2013;21(11):1627–37. 10.1016/j.joca.2013.07.017 .
    1. Lippross S, Moeller B, Haas H, Tohidnezhad M, Steubesand N, Wruck CJ, et al. Intraarticular injection of platelet-rich plasma reduces inflammation in a pig model of rheumatoid arthritis of the knee joint. Arthritis and rheumatism. 2011;63(11):3344–53. 10.1002/art.30547 .
    1. Wu CC, Chen WH, Zao B, Lai PL, Lin TC, Lo HY, et al. Regenerative potentials of platelet-rich plasma enhanced by collagen in retrieving pro-inflammatory cytokine-inhibited chondrogenesis. Biomaterials. 2011;32(25):5847–54. 10.1016/j.biomaterials.2011.05.002 .
    1. Raeissadat SA, Rayegani SM, Hassanabadi H, Fathi M, Ghorbani E, Babaee M, et al. Knee Osteoarthritis Injection Choices: Platelet- Rich Plasma (PRP) Versus Hyaluronic Acid (A one-year randomized clinical trial). Clinical medicine insights Arthritis and musculoskeletal disorders. 2015;8:1–8. 10.4137/CMAMD.S17894
    1. Andia I, Abate M. Knee osteoarthritis: hyaluronic acid, platelet-rich plasma or both in association? Expert opinion on biological therapy. 2014;14(5):635–49. 10.1517/14712598.2014.889677 .
    1. Ayhan E, Kesmezacar H, Akgun I. Intraarticular injections (corticosteroid, hyaluronic acid, platelet rich plasma) for the knee osteoarthritis. World journal of orthopedics. 2014;5(3):351–61. 10.5312/wjo.v5.i3.351
    1. Liebman J, Goldberg RL. Chondrocyte culture and assay. Current protocols in pharmacology / editorial board, SJ Enna. 2001;Chapter 12:Unit12 2. 10.1002/0471141755.ph1202s12 .
    1. Thompson CL, Yasmin H, Varone A, Wiles A, Poole CA, Knight MM. Lithium chloride prevents interleukin-1beta induced cartilage degradation and loss of mechanical properties. Journal of orthopaedic research: official publication of the Orthopaedic Research Society. 2015;33(10):1552–9. 10.1002/jor.22913 .
    1. Bernstein J. Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. The Journal of bone and joint surgery American volume. 2004;86-A(11):2567; author reply .
    1. Milano G, Deriu L, Sanna Passino E, Masala G, Manunta A, Postacchini R, et al. Repeated platelet concentrate injections enhance reparative response of microfractures in the treatment of chondral defects of the knee: an experimental study in an animal model. Arthroscopy: the journal of arthroscopic & related surgery: official publication of the Arthroscopy Association of North America and the International Arthroscopy Association. 2012;28(5):688–701. 10.1016/j.arthro.2011.09.016 .
    1. Sun Y, Feng Y, Zhang CQ, Chen SB, Cheng XG. The regenerative effect of platelet-rich plasma on healing in large osteochondral defects. International orthopaedics. 2010;34(4):589–97. 10.1007/s00264-009-0793-2
    1. Milano G, Sanna Passino E, Deriu L, Careddu G, Manunta L, Manunta A, et al. The effect of platelet rich plasma combined with microfractures on the treatment of chondral defects: an experimental study in a sheep model. Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society. 2010;18(7):971–80. 10.1016/j.joca.2010.03.013 .
    1. Saito M, Takahashi KA, Arai Y, Inoue A, Sakao K, Tonomura H, et al. Intraarticular administration of platelet-rich plasma with biodegradable gelatin hydrogel microspheres prevents osteoarthritis progression in the rabbit knee. Clinical and experimental rheumatology. 2009;27(2):201–7. .
    1. Kruger JP, Hondke S, Endres M, Pruss A, Siclari A, Kaps C. Human platelet-rich plasma stimulates migration and chondrogenic differentiation of human subchondral progenitor cells. Journal of orthopaedic research: official publication of the Orthopaedic Research Society. 2012;30(6):845–52. 10.1002/jor.22005 .
    1. Chen WY, Abatangelo G. Functions of hyaluronan in wound repair. Wound repair and regeneration: official publication of the Wound Healing Society [and] the European Tissue Repair Society. 1999;7(2):79–89. .
    1. Weigel PH, Fuller GM, LeBoeuf RD. A model for the role of hyaluronic acid and fibrin in the early events during the inflammatory response and wound healing. Journal of theoretical biology. 1986;119(2):219–34. .
    1. Chen WH, Lo WC, Hsu WC, Wei HJ, Liu HY, Lee CH, et al. Synergistic anabolic actions of hyaluronic acid and platelet-rich plasma on cartilage regeneration in osteoarthritis therapy. Biomaterials. 2014;35(36):9599–607. 10.1016/j.biomaterials.2014.07.058 .
    1. Fam H, Bryant JT, Kontopoulou M. Rheological properties of synovial fluids. Biorheology. 2007;44(2):59–74. .
    1. Blumberg BS, Ogston AG. The effects of proteolytic enzymes on the hyaluronic acid complex of ox synovial fluid. The Biochemical journal. 1957;66(2):342–6.
    1. Ogston AG, Stanier JE. On the state of hyaluronic acid in synovial fluid. The Biochemical journal. 1950;46(3):364–76.
    1. Ogston AG, Stanier JE. The physiological function of hyaluronic acid in synovial fluid; viscous, elastic and lubricant properties. The Journal of physiology. 1953;119(2–3):244–52.
    1. Balazs E. Viscoelastic properties of hyaluronan and its therapeutic use In Chemistry and Biology of Hyaluronan. Eds. Garg HG, and Hales C. A., editor. Amsterdam: Elsevier Ltd.; 2004.
    1. Thysen S, Luyten FP, Lories RJ. Targets, models and challenges in osteoarthritis research. Disease models & mechanisms. 2015;8(1):17–30. 10.1242/dmm.016881

Source: PubMed

3
Iratkozz fel